Global Home Healthcare Market Size Study, by Product (Therapeutic Products, Testing, Screening, and Monitoring Products, Mobility Care Products), by Service (Skilled Nursing, Rehabilitation Therapy, Hospice & Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, Pregnancy Care), by Indication (Cancer, Respiratory Diseases, Movement Disorders, Cardiovascular Diseases & Hypertension, Pregnancy, Wound Care, Diabetes, Hearing Disorders, Other Indications), and Regional Forecasts 2022-2032
Global Home Healthcare Market is valued at approximately USD 250.0 billion in 2023 and is anticipated to expand at a robust CAGR of 8.9% over the forecast period from 2024 to 2032. Home healthcare services, which provide both medical and non-medical care to individuals in the comfort of their homes, have gained significant traction in recent years. This growth is primarily driven by the rising prevalence of chronic illnesses, the aging population, and advancements in home healthcare technologies. These services range from skilled nursing care and therapy to personal assistance with daily living activities, allowing patients to recover, manage chronic conditions, or receive ongoing care in a familiar and comfortable environment.
The global home healthcare market is poised for substantial growth due to a sharp increase in the number of older people and the prevalence of chronic illnesses. According to the UN Department of Economic and Social Affairs, the global population of individuals over 65 is expected to rise from 771 million in 2022 to 1.6 billion by 2050. This demographic shift, coupled with the fact that older individuals are more susceptible to chronic diseases, is expected to place a significant burden on healthcare systems. Home healthcare provides a cost-effective solution, reducing the need for hospital stays, readmissions, and the time and expense associated with traveling to healthcare facilities.
Another significant driver of market growth is the growing focus on newer technologies such as telehealth, which allows home healthcare providers to offer continuous care and monitoring even when they are not physically present. Telehealth encompasses a range of services, including virtual medical consultations, remote patient monitoring, and educational resources. These services enable healthcare providers to assess patients' conditions, offer appropriate care, and even refer them for additional treatment when necessary. As a result, telehealth is becoming increasingly popular among patients, further bolstering the home healthcare market.
Despite the positive outlook, the market faces challenges such as limited insurance coverage and a shortage of homecare workers. While insurance coverage for home healthcare services is available in many regions, it is often restricted to organizations that have received specific certifications, and coverage for equipment such as multi-parameter monitoring devices and remote monitoring tools varies significantly. Additionally, the growing demand for home healthcare services has led to a shortage of qualified homecare workers, which could limit the market's growth potential.
The key regions considered for the global Home Healthcare Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America currently holds the largest share of the home healthcare market, driven by the high prevalence of chronic illnesses and the region's well-established healthcare infrastructure. However, the Asia Pacific region is expected to experience the highest growth rate during the forecast period, fueled by the rising prevalence of chronic diseases and increasing healthcare costs in the region.
Major market players included in this report are:B. Braun Melsungen AG
Abbott
Sunrise Medical
3M Healthcare
Baxter International Inc.
Medtronic PLC
Cardinal Health Inc.
F. Hoffmann-La Roche AG
Air Liquide
Amedisys, Inc.
Arkray, Inc.
BD
Omron Healthcare, Inc.
Drive DeVilbiss Healthcare
GE Healthcare
The detailed segments and sub-segment of the market are explained below:By Product
• Therapeutic Products
• Testing, Screening, and Monitoring Products
• Mobility Care Products
By Service
• Skilled Nursing
• Rehabilitation Therapy
• Hospice & Palliative Care
• Unskilled Care
• Respiratory Therapy
• Infusion Therapy
• Pregnancy Care
By Indication
• Cancer
• Respiratory Diseases
• Movement Disorders
• Cardiovascular Diseases & Hypertension
• Pregnancy
• Wound Care
• Diabetes
• Hearing Disorders
• Other Indications
By Region:
• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of the geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand-side and supply-side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.